ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0708

Association Of Choroidal Sub-foveal Thickness With Skin Manifestations And Serum Monocyte HDL Ratio In Patients With Systemic Sclerosis-A Case Control Study

Tejaswini Ramineni1, Vijaya prasanna Parimi2, Radhika M3 and Narsimulu Gumdal3, 1Esic Medical College And Hospital, Sanathnagar, Hyderabad, Telangana, India, 2ESIC Medical College and Super Specilaity Hospital, hyderabad, Telangana, India, 3ESIC MEDICAL COLLEGE AND HOSPITAL, Hyderabad, Telangana, India

Meeting: ACR Convergence 2025

Keywords: Eye Disorders, Monocytes/macrophages, Raynaud's, Systemic sclerosis, Ulcers

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0671–0710) Systemic Sclerosis & Related Disorders – Clinical Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: The vascular hypothesis in systemic sclerosis (SSc) posits that vasculopathy is the initial inciting event that triggers inflammation and subsequent fibrosis in the progression of the disease. The primary objective of this study was to evaluate the association of serum MHR with skin manifestations, including Raynaud’s phenomenon (assessed via the Raynaud’s Condition Score), digital ulcers (measured by the Digital Ulcer Score), and skin fibrosis (evaluated using the Modified Rodnan Skin Score) in patients with SSc. The secondary objectives included assessing choroidal subfoveal thickness in SSc patients and investigating the associations between choroidal thickness, MHR, and skin manifestations.

Methods: After obtaining approval from the Institutional Ethics Committee (IEC), this case-control study was conducted at ESIC Medical College and Hospital in Telangana, India. A total of 35 adult patients with systemic sclerosis and 35 age- and gender-matched healthy controls were recruited, all of whom met the inclusion criteria. Serum monocyte-to-HDL cholesterol ratio (MHR) was calculated and compared between the two groups. High-definition optical coherence tomography (HD-OCT) was used to measure choroidal subfoveal thickness, and these measurements were also compared between the groups. Correlations between serum MHR values, choroidal subfoveal thickness and skin manifestations among systemic sclerosis patients were analyzed. Statistical analysis was performed using SPSS Version 21, with significance set at p< 0.05.

Results: In our study, both groups consisted of 35 individuals, with 30 females in each group. The mean age was 37.6 years in systemic sclerosis patients and 38.9 years in healthy controls. The mean MHR was significantly higher in patients with systemic sclerosis compared to healthy controls (p< 0.05). Choroidal subfoveal thickness was significantly lower in patients than in controls (p< 0.05).While MHR values showed a positive correlation with markers of peripheral microvascular involvement—such as the Raynaud's Condition Score (RCS), Digital Ulcer Score (DUS), and skin fibrosis assessed by the Modified Rodnan Skin Score (MRSS)—statistical significance was not achieved. Choroidal subfoveal thickness exhibited a negative correlation with all skin parameters asessed.

Conclusion: The findings from this study support the use of non-invasive techniques, such as high-definition optical coherence tomography (HD-OCT), for evaluating choroidal microvasculature in patients with systemic sclerosis, even at early stages of the disease. Additionally, the study suggests that the monocyte-to-HDL cholesterol ratio (MHR) may serve as a simple, cost- effective, and easily measurable serum biomarker. MHR could help identify SSc patients at higher risk for vasculopathy, including digital ulcers and more advanced skin fibrosis.As an indirect marker of oxidative stress and inflammation, MHR showed a correlation with changes in choroidal microvasculature. Therefore, combining MHR with choroidal vascular evaluation provides valuable adjunctive diagnostic support for assessing overall microcirculation in patients with systemic sclerosis.

Supporting image 1Comparison of Monocyte-to-HDL Ratio Between Systemic Sclerosis Patients and Healthy Controls

Supporting image 2Comparison of Choroidal Sub-foveal Thickness using HD-OCT Between Systemic Sclerosis Patients and Healthy Controls


Disclosures: T. Ramineni: None; V. Parimi: None; R. M: None; N. Gumdal: None.

To cite this abstract in AMA style:

Ramineni T, Parimi V, M R, Gumdal N. Association Of Choroidal Sub-foveal Thickness With Skin Manifestations And Serum Monocyte HDL Ratio In Patients With Systemic Sclerosis-A Case Control Study [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/association-of-choroidal-sub-foveal-thickness-with-skin-manifestations-and-serum-monocyte-hdl-ratio-in-patients-with-systemic-sclerosis-a-case-control-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-of-choroidal-sub-foveal-thickness-with-skin-manifestations-and-serum-monocyte-hdl-ratio-in-patients-with-systemic-sclerosis-a-case-control-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology